allowed a relatively accurate prediction as to the presence or absence of the gene>"; these have not, however, been of use in the absence of an appropriate family structure, which has limited their value.
The recent identification, by ourselves and others, of a specific gene defect in myotonic dystrophy'2"'4 now allows us the possibility of using molecular techniques in the diagnosis of this disorder. The defect is the expansion of an unstable CTG sequence in a gene whose predicted protein product is a member ofthe protein kinase family, " the degree of expansion of the sequence showing a relation to the clinical features of the disease. 6 This CTG repeat sequence is located in the 3' untranslated region of the gene. Normal individuals have up to 30 copies of the repeat but in DM the number ranges from 50 to more than 2000. We here report our early experience in using this new investigation in the assessment of myotonic dystrophy patients and relatives in whom cataract has been the principal clinical feature, and where lens opacities have been important in diagnostic conclusions.
Myotonic dystrophy (dystrophia myotonica, DM), the commonest form of adult muscular dystrophy,' was first recognised in 190923; by 1911 Greenfield4 had already recognised an association with cataract, while by 1918 Fleischer' had shown that cataract could occur in generations preceding full myotonic dystrophy and that different pedigrees could be connected through individuals affected by cataract alone. He proposed the concept of anticipation, in which clinical features were progressively more serious and of earlier onset in successive generations, with cataract being the initial and mildest feature of the disease, especially in the earlier generations. Fleischer and, later, Vogt6 also recognised the specific nature of the lens changes in the disorder, multicoloured, crystalline, subcapsular opacities being visible with the slit-lamp before any cataract appeared producing visual symptoms.
The highly variable neuromuscular features of myotonic dystrophy, ranging from fatal neonatal disease due to respiratory inadequacy, to minimal myotonia in later life, have caused considerable difficulties in genetic counselling, particularly in the exclusion of the gene in relatives at risk. Slit-lamp examination of the lenses has always been recommended as an essential part of the investigation of such individuals, and most studies have shown a small but definite proportion with specific lens abnormalities who would not otherwise have been recognised.7
Over the past 5 This family came to attention when IV-1 (Fig 1) was born and features of the congenital form of myotonic dystrophy were recognised, with hypotonia, bilateral talipes, feeding problems, and subsequent delayed motor and intellectual development. Examination of the mother (III-4) confirmed the presence of clinical myotonia. Her sisters III-1 and III-6 were likewise found to have clear clinical evidence of myotonic dystrophy and, although III-1 had been attending an infertility clinic for 3 years, the underlying cause of her infertility had not been recognised. Slit-lamp ophthalmic examination in both III-1 and III-6 was normal.
On examination at the age of 70, II-I was noted to have a long face but there was no evidence of myopathy or of grip or percussion myotonia. He had had bilateral cataract removal aged 51 as had his sister (II-3) who went on to develop symptomatic muscle disease in her 60s.
Molecular analysis (Fig 2) confirmed that II-1 was the gene carrier; he is heterozygous for the EcoRI polymorphism of M10M6 and shows an expansion of 0.18 kb in the 10 kb allele using PCR analysis. His wife is homozygous for the 9 kb allele and there is a progressive enlargement of the paternal 10 kb allele as it is transmitted to III-4 and subsequently to IV-1. This intergenerational molecular instability manifests clinically as the anticipation observed in this family and recognised many years ago to be a feature of the disorder. CASE 
2
This 78-year-old man came to our attention when his daughter (II-1, Fig 3) was diagnosed with classic features ofmyotonic dystrophy, including bilateral posterior polar cataract at the age of 39 years. Her parents were subsequently investigated. The mother (1-2) aged 63, was clinically normal and had a normal EMG. Her slit-lamp examination showed early non-specific lens opacities thought to be age related. The father I-I aged 73 was clinically normal as was his EMG. Slit-lamp examination showed bilateral subcortical and subcapsular lens opacities with bilateral posterior polar early cataract. Confirmation of the father as the gene carrier required PCR analysis to demonstrate minimal expansion (55 repeats) at the myotonic dystrophy locus. Figure  4 shows the progressive enlargement in the grandpaternal allele as it is transmitted through II-1 to III-1 (he has inherited a normal 10 kb allele from his father). CASE 3 This 70-year-old woman (1-2, Fig 5) Molecular analysis of the myotonic d locus showed that the expanded allel mother was not present in the proband therefore reassured that it was most unl she had inherited the gene for DM. Figure 6 Pedigreefor case 5. Typings refer to the BCLSIM1uI and EcorRI polymorphisms. II-2 has inherited, from her affectedfather, the opposite allele (1) of -10 kb this closely linked polymorphism to that inherited by her two affected brothers (allele 2).
-9 kb sought predictive testing before marriage. Clinical and EMG examinations were normal. Slitlamp examination showed no polychromasia but 0 an widespread white anterior cortical opacities of rlysis) but the lens were observed bilaterally. These were I kb allele fe'lt to be abnormal in a patient of this age.
Molecular prediction by the linked DNA probe BCL3 showed her to be at low risk of having inherited the gene for myotonic dysbe at low trophy as she had inherited the opposite paternal myotonic allele to her affected brothers (see Fig 6) . Howto have ever, as this result was reached using linkage analysis the possibility that a recombination had d showed taken place between the linked probe and the ir opacity myotonic dystrophy gene could not be disFelt to be counted. Thus, it was not possible to counsel this it was felt woman accurately as to her specific risk for r changes myotonic dystrophy in view of the dichotomy myotonic between molecular and ophthalmic findings.
Subsequent analysis for the specific mutation lystrophy showed no evidence of the expansion associated le in her with myotonic dystrophy, confirming the result . She was based on linkage and indicating that the ophikely that thalmic findings were not related to myotonic dystrophy. CASE 5 This 32-year-old woman ( disorder, a significant observation since polychromatic opacities have been considered to be specific for myotonic dystrophy. Figure 1 , where the increase in expansion can be seen to correlate with the increasing severity in successive generations. Despite Fleischer's early recognition of this phenomenon in 1918, it was for many years considered to result from ascertainment bias rather than from true biological variation in the genetic defect. 9 Since cataract is often the only abnormality in minimally affected members of the older generations of myotonic dystrophy families, considerable diagnostic significance has rested on the interpretation of the ocular findings in such individuals. Cataracts may already be dense or may have been removed when the possibility of myotonic dystrophy is first raised, leaving very real doubts as to their significance. Thus the confirmation of a molecular abnormality, as in cases 1 and 2, is of considerable importance in genetic counselling for younger generations of the family.
Since cataracts in the elderly are so frequent it would seem wise to obtain molecular confirmation before coming to a conclusion on the relation between cataract and myotonic dystrophy in such a situation. This can be done using a blood or mouthwash sample to obtain DNA; in view of the minimal expansion likely in patients with cataract only, it is important that accurate quantitation of the DNA expansion, using PCR based techniques, is undertaken, since Southern blotting (as shown in Fig 1) is less sensitive in the detection of such small changes.
In the studies that have so far compared the use of slit-lamp and EMG investigations in relatives at risk with results of linked DNA markers,202' most cases showed concordance between the results of these two approaches, but there were also instances" where a low risk was predicted by DNA markers but where lens opacities thought to be specific were present, as in case 4 of our series (this individual was reported as case 2 in Reardon et al"). Molecular analysis for the specific mutation should now be able to resolve such discrepancies and will relieve the uncertainty caused by apparently opposing results. It could be argued that a 'normal result' on mutation analysis of DNA extracted from peripheral blood lymphocytes does not exclude the possibility that an individual is 'mosaic' for the DM mutation. While there is a theoretical possibility ofa mutant germ cell (sperm or egg) giving rise to both mutant and normal cells in subsequent mitotic divisions, with resultant 'mosaicism' which may be tissue specific, this has not been reported in DM. Very large expansions in the repeat sequence are prone to somatic instability which is seen as a smear on analysis. It Patients with myotonic dystrophy are not infrequently first seen by ophthalmologists because ofcataract. Most such patients prove, on wider investigation, to show myotonia and other neurological abnormalities, or to have relatives with such involvement. Occasionally, however, an apparent case of 'myotonic cataract' is seen with typical ophthalmic features but with no other evidence of myotonic dystrophy in the patient or in family members. Case 7 in our series illustrates this situation, one which understandably produced considerable concern, and which could not have been fully resolved without the aid of the specific molecular investigation. It thus seems likely that not all cases of early cataract suggestive of myotonic dystrophy will be due to this disorder; study of larger numbers of such cases will be needed before firm conclusions can be reached on the specificity of the ophthalmic findings. We are currently investigating other such cases and are also examining a series of unselected cataract patients to determine whether a significant number of them show the myotonic dystrophy mutation. It is possible that minimal gene carriers may be commoner in the population than has hitherto been recognised.
A final unanswered question relates to how the specific mutation in the myotonic dystrophy gene produces cataract, and why this abnormality should so often occur in patients with small DNA expansions in whom neuromuscular abnormalities are minimal. The predicted protein sequence of the gene shows strong homology with the protein kinase family ofenzymes,'5 but a more precise relationship of the lens disturbance and the molecular defect will require isolation and characterisation of this protein. Since the unstable sequence occurs in the 3' untranslated region of the gene, it is possible that it exerts its effect indirectly through the DNA expansion, rather than by the production of a structurally abnormal protein. It is also possible that the cataract could result from disrupted function of a different part of the gene from that involved in the neuromuscular abnormality, or even from disturbance of an adjacent gene.
The recognition of a specific molecular abnormality in myotonic dystrophy now means that these and other important questions can be addressed, even if they cannot immediately be answered. Meanwhile the discovery provides a test that should be of practical value in resolving the ophthalmic diagnostic problems that are encountered in myotonic dystrophy patients and their relatives.
